Hospital for Special Surgery, New York, NY, USA.
Department of Orthopaedic Surgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Foot Ankle Int. 2022 Oct;43(10):1300-1307. doi: 10.1177/10711007221108098. Epub 2022 Jul 1.
There has been concern about lateral prominence pain at the osteotomy site following medial displacement calcaneal osteotomy (MDCO). However, no study has investigated this complication. This study aimed to investigate the incidence of lateral prominence pain following MDCO and examine the efficacy of crushplasty as a surgical technique to minimize this complication.
This was a retrospective cohort study in which 137 patients (148 feet) who underwent MDCO were divided into 2 groups by whether they had concurrent crushplasty at the time of MDCO (crushplasty [n = 81] vs noncrushplasty group [n = 67]). Crushplasty was performed by flattening the bony step-off using a rongeur and bone impactor. Lateral prominence pain was defined as pain or irritating symptoms over the osteotomy site that persisted over 12 months after MDCO. The overall incidence of lateral prominence pain after MDCO and within each group was investigated. Multiple logistic regression analysis was used to determine the influence of possible risk factors on the development of postoperative lateral prominence pain.
The overall incidence of lateral prominence pain was 9.5% (14 of 148): 3.4% (3 of 87) in the crushplasty group, and 18% (11 of 61) in the noncrushplasty group, and χ analysis showed a statistically significant relationship between crushplasty and lateral prominence pain ( < .05). A relationship between the amount of medial displacement and the development of lateral prominence pain was observed in the noncrushplasty group (OR = 5.31, 95% CI 2.35-16.4, < .05), but this was not observed in the crushplasty group ( = .641). The amount of medial displacement was an independent risk factor for the development of lateral prominence pain (OR = 2.72, 95% CI 1.54-4.79, < .05), and concurrent crushplasty had a negative relationship with lateral prominence pain development (OR = 0.12, 95% CI 0.03-0.57, < .05).
This study revealed that lateral prominence pain is a significant complication of MDCO, especially in the setting of a larger displacement. The crushplasty following MDCO may minimize this complication, particularly when a greater degree of hindfoot correction is attempted.
内侧移位跟骨截骨术(MDCO)后,在截骨部位出现外侧突出疼痛一直存在争议。然而,目前还没有研究对此并发症进行调查。本研究旨在调查 MDCO 后外侧突出疼痛的发生率,并研究整形术作为一种减少该并发症的手术技术的疗效。
这是一项回顾性队列研究,137 例(148 只脚)接受 MDCO 的患者根据 MDCO 时是否同时进行整形术(整形术组[n=81]与非整形术组[n=67])分为两组。整形术是通过使用咬骨钳和平整骨冲击器使骨台阶变平来完成的。外侧突出疼痛定义为 MDCO 后 12 个月以上持续存在的截骨部位疼痛或刺激性症状。研究了 MDCO 后外侧突出疼痛的总体发生率以及每组内的发生率。采用多因素逻辑回归分析确定可能的危险因素对术后外侧突出疼痛发生的影响。
外侧突出疼痛的总发生率为 9.5%(14/148):整形术组为 3.4%(3/87),非整形术组为 18%(11/61),χ2 分析显示整形术与外侧突出疼痛之间存在统计学显著关系(<0.05)。在非整形术组中观察到内侧移位量与外侧突出疼痛的发生之间存在关系(OR=5.31,95%CI 2.35-16.4,<0.05),但在整形术组中未观察到这种关系(=0.641)。内侧移位量是外侧突出疼痛发生的独立危险因素(OR=2.72,95%CI 1.54-4.79,<0.05),而同期整形术与外侧突出疼痛发生呈负相关(OR=0.12,95%CI 0.03-0.57,<0.05)。
本研究表明,外侧突出疼痛是 MDCO 的一个严重并发症,尤其是在较大位移的情况下。MDCO 后进行整形术可能会减少这种并发症,特别是在尝试更大程度的后足矫正时。